Skip to main content
Log in

Anticoagulation therapy in glaucoma surgery

  • Glaucoma
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To identify the practices of ophthalmologists when undertaking glaucoma surgery on patients concurrently using warfarin or acetylsalicylic acid (aspirin).

Methods

A questionnaire was designed to examine perioperative management of patients being treated with warfarin and aspirin prior to and during glaucoma surgery. The questionnaire was posted with stamped self-addressed envelopes to all glaucoma specialists registered on a glaucoma shared care scheme database.

Results

Of the 93 eligible participants, 64 returned a completed questionnaire, representing a response rate of 68.8%. Twenty-one surgeons (32.8%) routinely stopped warfarin before surgery. Mean time prior to surgery of drug cessation was 4 days (range 2–7). Three surgeons (14.3%) routinely commenced heparin if they stopped warfarin. Ten (47.6%) never used heparin, while the remaining eight (38.1%) would use heparin depending upon the indication for anticoagulation. Forty-two surgeons (81.25%)were happy to operate only at an INR ≤3 at the time of surgery. The remainder (18.75%) were happy to operate at higher INRs, including two surgeons (3.1%) who would operate at any level. Twenty surgeons (31.2%) routinely stopped aspirin before surgery, while the rest did not. Of those who stopped aspirin, the mean time prior to surgery was 7.1 days (range 4–14 days).

Conclusions

The majority of surgeons do not stop warfarin or aspirin prior to glaucoma surgery. There is a great diversity in current practice with regard to the management of anticoagulant therapy prior to glaucoma surgery amongst glaucoma surgeons in England. Currently there is little information available to offer definitive guidance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. The Medical Research Council’s General Practice Research Framework (1998) Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 351(9098):233–241

    Article  Google Scholar 

  2. Antithrombotic Trialists’ Secretariat (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71–86

    Article  Google Scholar 

  3. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E (2003) Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 110(2):359–362 discussion 362–3644

    Article  PubMed  Google Scholar 

  4. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348(10):891–899

    Article  PubMed  CAS  Google Scholar 

  5. Parkin B, Manners R (2000) Aspirin and warfarin therapy in oculoplastic surgery. Br J Ophthalmol 84(12):1426–1427

    Article  PubMed  CAS  Google Scholar 

  6. Konstantatos A (2001) Anticoagulation and cataract surgery: a review of the current literature. Anaesth Intensive Care 29(1):11–18

    PubMed  CAS  Google Scholar 

  7. Ong-Tone L, Paluck EC, Hart-Mitchell RD (2005) Perioperative use of warfarin and aspirin in cataract surgery by Canadian Society of Cataract and Refractive Surgery members: survey. J Cataract Refract Surg 31(5):991–996

    Article  PubMed  Google Scholar 

  8. Narendran N, Williamson TH (2003) The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand 81(1):38–40

    Article  PubMed  Google Scholar 

  9. Cobb CJ, Chakrabarti S, Chadha V, Sanders R (2007) The effect of aspirin and warfarin therapy in trabeculectomy. Eye 21(5):598–603

    PubMed  CAS  Google Scholar 

  10. Bell NP, Orengo-Nania S, Pietz K, Gross RL (2004) Aspirin use in advanced uncontrolled glaucoma. J Glaucoma 13(5):365–370

    Article  PubMed  Google Scholar 

  11. Fraser SG, Wormald RP (2008) Hospital Episode Statistics and changing trends in glaucoma surgery. Eye 22(1):3–7

    Article  PubMed  CAS  Google Scholar 

  12. Grip L, Blomback M, Schulman S (1991) Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. Eur Heart J 12(11):1225–1233

    PubMed  CAS  Google Scholar 

  13. Dahlmann AH, Mireskandari K, Cambrey AD, Bailly M, Khaw PT (2005) Current and future prospects for the prevention of ocular fibrosis. Ophthalmol Clin North Am 18(4):539–559

    PubMed  Google Scholar 

  14. Sii F, Todd B, Shah P, Chiang M (2006) Reduction of anterior-segment vascularity with preoperative topical apraclonidine 1%. J Cataract Refract Surg 32(4):692–693

    Article  PubMed  Google Scholar 

  15. Konstas AG, Jay JL (1992) Modification of trabeculectomy to avoid postoperative hyphaema. The ‘guarded anterior fistula’ operation. Br J Ophthalmol 76(6):353–357

    Article  PubMed  CAS  Google Scholar 

  16. King AJ, Rotchford AP, Alwitry A, Moodie J (2007) Frequency of bleb manipulations after trabeculectomy surgery. Br J Ophthalmol 91(7):873–877

    Article  PubMed  CAS  Google Scholar 

  17. Gore-Felton C, Koopman C, Bridges E, Thoresen C, Spiegel D (2002) An example of maximizing survey return rates. Methodological issues for health professionals. Eval Health Prof 25(2):152–168

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. J. King.

Appendix

Appendix

Anticoagulation in glaucoma surgery questionnaire

Postcode of hospital (1st half): ________________

Q1: How many glaucoma surgeries do you perform per year?____________

__________ % Trabeculectomy ___________ % Non-penetrating

Q2: a) Do you routinely stop Warfarin treatment before trabeculectomy? Y / N

If so how far in advance? ________ days Why?______________

b) Do you liase with a haematologist about stopping Warfarin?

Y / N / Dependant on reason for Warfarin

Reasons warranting haematology consultation (please circle all that apply):

AF / DVT / PE / Porcine Heart Valve / Metal Heart Valve

c) Do you liase with the patients GP about stopping their Warfarin?

Y / N / Dependant on reason for Warfarin

Reasons warranting GP consultation (please circle all that apply):

AF / DVT / PE / Porcine Heart Valve / Metal Heart Valve

d) If you stop Warfarin do you use IV heparin instead?

Y / N / Dependant on reason for Warfarin (go to 2e)

e) What conditions do you consider warrant IV heparin instead of Warfarin?

AF / DVT / PE / Porcine Heart Valve / Metal Heart Valve

(please circle all that apply)

f) In patients on Warfarin (whether you’ve stopped it or not) when do you check the INR (please circle all that apply):

The day of operation / 1 week before / 2 weeks before

Q3: a) Do you routinely stop Aspirin before trabeculectomy? Y / N

If so how far in advance? ________ days Why? _______________

b) Do you liase with the patients GP about stopping their Aspirin?

Y / N / Dependant on reason for Aspirin (go to Q3c)

c) Reasons warranting GP consultation before stopping Aspirin:

AF / DVT / PE / History of CVA / History of TIA

IHD / History of MI

Q4: At what INR would you be unhappy proceeding to surgery (please circle)?

>1.0 >1.5 >2.0 >2.5 >3.0 >3.5 >4.0 Happy at any INR

Q5: a) Do you recall your last haemorrhagic complication following trabeculectomy?

Y / N / Never had a haemorrhagic complication

b) If so – was the patient on (please circle):

Warfarin / Aspirin / Both Aspirin and Warfarin / None /

Clopidogrel

c) If the patient was on Warfarin did you stop it pre-operatively Y / N

How many days pre-operatively? _________ days

Did you check the INR? Y / N When? ___ days pre-op

INR was ________ (approx figure fine – leave blank if cannot recall)

d) If the patient was on Aspirin did you stop it pre-operatively Y / N

How many days pre-operatively? _________ days

e) What was the complication (please circle all that apply):

Excessive Peroperative Haemorrhage

Post-operative Hyphaema

Post-op sub-conj Haemorrhage

Supra-Choroidal Haemorrhage

Bleed under flap or at ostium

Other:___________________________

f) How did you manage this complication?

Expectant / Active

Surgical revision / tPA injection / AC washout

Other: ________________________________________

Q6: a) Do you recall the last patient you operated upon on Warfarin? Y / N

b) Is this patient the same as the one described above? Y / N

If yes please skip this question (go to Q7)

c) Did you stop the Warfarin pre-operatively Y / N

d) If yes how many days pre-operatively? ________ days

e) Did you check the INR? Y / N

INR was ________ (approx) at time of surgery

f) Was there excessive bleeding per-operatively Y / N

g) Was there any post-operative haemorrhagic complication Y / N

If so what complication (please circle all that apply):

Excessive Peroperative Haemorrhage

Post-operative Hyphaema

Post-op sub-conj Haemorrhage

Supra-Choroidal Haemorrhage

Bleed under flap or at ostium

Other:________________

h) How did you manage this complication?

Expectant / Active

Surgical revision / tPA injection / AC washout

Other: ________________________________________

Q7: Have you carried out a trabeculectomy upon a patient on Clopidogrel?

Y (go to Q7a) / N (go to Q7b)

a) Did you stop the drug? Y / N

How long before surgery: _______ days

Was there excessive per-operative bleeding? Y / N

Were there any post-operative bleeding complications? Y / N

What was the complication: ________________________

b) If you operate on someone on Clopidogrel do you intend to stop the drug? Y / N

If so how long before surgery: _______ days

Comments:

 

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alwitry, A., King, A.J. & Vernon, S.A. Anticoagulation therapy in glaucoma surgery. Graefes Arch Clin Exp Ophthalmol 246, 891–896 (2008). https://doi.org/10.1007/s00417-008-0792-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-008-0792-9

Keywords

Navigation